This is to notify all Participants that Farmaforce Limited (Voluntary Administrator Appointed) (the “Company”) has advised ASX Settlement Pty Ltd (ASX Settlement) (ABN 49 008 504 532) of the appointment of voluntary administrators on 10 March 2022. Financial Products of the Company have been suspended from official quotation on ASX Limited since 01 March 2022 under Listing Rule 17.5, following FFC’s failure to lodge the relevant periodic report by the due date.

What do I need to do by when?

Suspension from CHESS approval took effect on 11 March 2022

Pursuant to ASX Settlement Operating Rules 8.4.1(a) and 8.4.1(d), ASX Settlement has suspended the above listed class of the Issuer’s approved Financial Products following the appointment of administrators until further notice.

Participants are advised that, as a result of the Company’s suspension of approval in respect of the above listed class of the Issuer’s approved Financial Products, CHESS will not process Messages affecting Holder registration details. In addition transfer and/or Conversion Messages will not be processed, unless the administrator gives written consent or a Court order authorises the transfer of the securities.

Need more information?

Issued by

Darren Tay, Equity Operations                              

Contact information

Equity Operations
1800 814 051
chesshelp@asx.com.au

Disclaimer